A common solution to group 2 influenza virus neutralization - sprookjes - yvandenbroek - TriplyDB

A common solution to group 2 influenza virus neutralization

A common solution to group 2 influenza virus neutralization

http://www.wikidata.org/entity/Q27680873

about

Stable long-term cultures of self-renewing B cells and their applications Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding Universal influenza virus vaccines and therapeutic antibodies.Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine Continuing challenges in influenza.In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice Novel universal influenza virus vaccine approaches The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.Options and obstacles for designing a universal influenza vaccine Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure.Structure and immune recognition of trimeric pre-fusion HIV-1 Env.Influenza virus antigenicity and broadly neutralizing epitopes.Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.

P2860

Q26766723-FE25C132-6D4F-41E3-99FA-97D5F749D93C Q26783897-20DB6A04-0C47-44C1-8581-19C915212A41 Q26823492-D3F0E308-5AE0-42FA-971C-25277025C524 Q27683156-7B7A69C9-AB29-460B-A422-6CA74E0FE569 Q27683187-31DC32C0-ECBF-4748-BC49-0ABA63ACC619 Q27701889-CE994229-0F17-481F-91E7-5CF146A778E7 Q28075274-F9BE79A2-9588-473D-B547-6B8F2DF2A5FF Q28077984-E7E75442-03A1-46E4-A46D-8CCEE5A5A5A2 Q28552195-21713B64-E6B1-4DB1-A65C-67C38E792C6B Q28552622-2EE4B8B9-5169-49FF-B1B9-8E6303B4C2EA Q30151337-8511493E-9D3D-4E33-9431-98DEEEB4F221 Q30207889-972014AB-FBF9-4445-8C36-2DAA04ED0FEC Q30209342-90A97903-FEDA-42FB-8292-5A31B88176DE Q30234558-269FA59D-5C07-4E26-8500-B017342370FF Q30363190-2956E246-68F2-4BFC-8AFD-525D74840BD8 Q30364943-5B431010-B547-4CCE-BEC5-4236EE81BE34 Q30371836-8CF7F0B3-3FB6-475E-9684-08DD1CA92074 Q30372274-F1CDF466-A1CE-468C-B759-17ECFDED1641 Q30376605-F8E4B5BF-BFCB-4BC9-9DDE-68C08444BC50 Q30376724-D595B935-4100-4E18-8E66-B50E1909207C Q30380785-694CA201-EA66-495A-BEB4-1DE3395EDFB8 Q30385071-156992F6-012C-4EED-91AF-7AB23C9E7F62 Q30387177-0C42F30C-E79E-4D3D-8A84-8A337B1E1DDB Q33553746-7853069D-1CA8-4E92-8099-805015D64103 Q33815658-75FDA93B-EF34-405A-BD3C-2CD3583E5EB9 Q34102290-89D6D5D9-FBD9-466D-8E1E-D10F2EB247F6 Q34594065-47F31678-54F5-4EDA-94CD-AD92F642A008 Q34601167-824BBE0C-21D2-46B6-9206-F44D3A0413BB Q34650084-C73504DE-B114-4841-9C85-B4D71726AA2F Q35142291-C662D6F1-AC59-46B0-B9E0-6A49FEC70D02 Q35685270-FECF5867-FD30-4F34-9C9F-78FCDB78AA23 Q35756765-4CC4BF02-69AA-4EE0-9CB3-26A20F2B3E07 Q35758670-DB2627E7-0E8F-49AB-A8CD-951800264AD6 Q36496580-07D463F7-3523-4179-A38F-F8C4ED2EEDD1 Q36991414-BC90E708-05E6-410A-AB69-82C2DE6A1881 Q37140197-D7EC115A-D7C6-41AE-8167-09C5F490C608 Q37323172-F7C0A9DD-B290-44D0-8D3A-A9F6B0FBC896 Q37714300-1A206980-7BAF-4811-92CA-0E69A31523D9 Q38804059-AE028AEE-A9C5-452C-ABFA-3D8F8FCA36E4 Q39397313-8B29ECA8-92B0-4075-A853-BAC120741623

P2860

A common solution to group 2 influenza virus neutralization

http://www.wikidata.org/entity/Q27680873

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A common solution to group 2 influenza virus neutralization

@ast

A common solution to group 2 influenza virus neutralization

@en

A common solution to group 2 influenza virus neutralization

@nl

type

label

A common solution to group 2 influenza virus neutralization

@ast

A common solution to group 2 influenza virus neutralization

@en

A common solution to group 2 influenza virus neutralization

@nl

prefLabel

A common solution to group 2 influenza virus neutralization

@ast

A common solution to group 2 influenza virus neutralization

@en

A common solution to group 2 influenza virus neutralization

@nl

P1433

Q27680873-BE0D25A3-D552-44C4-B15C-1E8BAB42E557

P1476

Q27680873-33D75217-8399-4944-B0FF-7CB48436DC07

P2093

Q27680873-23E9AA35-EC53-487A-A9D9-7E0234C619C3

Q27680873-24778004-2747-487A-9FF5-5842F0D4B74A

Q27680873-7FDB91F3-99C5-4F26-9577-6CCAC6C56829

Q27680873-9A449295-9883-47A5-B8F5-1E026D6D58E3

Q27680873-9C8FCC45-9C96-4941-82A4-0A6CA7D0B876

Q27680873-A2052CC2-0924-4C69-B882-F29D1C638C9A

Q27680873-A437AD54-D7A9-4A6D-AFF8-5243DD74D2D2

Q27680873-B1D61643-53B7-4697-80A9-B1C7F38C8907

Q27680873-B6BE8966-6558-4F25-9DF1-2A5979B562D4

Q27680873-D96EE3D0-3667-4E1A-990C-354417C470B2

P2860

Q27680873-05E8A698-8D2C-4DC8-A463-AAA9A582AD77

Q27680873-0751EBA3-EC57-4C26-BCCC-68CE12AFE64D

Q27680873-09A84D5D-DE31-4A11-B3E3-D05CD67751D8

Q27680873-0E0082D9-E3D9-45EF-8147-BF3D2C926912

Q27680873-17CF35BC-5B51-4287-BA07-E97AF107ED72

Q27680873-188CB831-89F1-4C4E-A4B3-094058C83D2B

Q27680873-198E9047-B5B8-4B13-AABE-E80B150C3C54

Q27680873-2834F97D-8989-4304-AA42-5F5FA822AB1F

Q27680873-2ABD9331-9EF9-4C98-9D13-7FABFB8DB750

Q27680873-30D04043-FF00-46E5-A2CC-16D0E8D9089B

P304

Q27680873-7DEE182E-42AC-4E38-A588-4D4BD2A06C8E

P31

Q27680873-6D3C0359-E191-4EC3-B82B-2306BE1ECC2B

P3181

Q27680873-00F58802-5BBF-4286-B686-1892453932B3

P356

Q27680873-2D507E41-6F2C-4CE8-BFF3-8B2E35ED04E9

P407

Q27680873-BA256CC4-C34D-4850-BA07-23033EC689A0

P433

Q27680873-4D3B7A52-275C-4416-A446-022E128DF389

P478

Q27680873-CA1103E1-ED63-43DC-B49B-E54013A053A9

P50

Q27680873-307F254D-4329-4C9E-9B10-202BC8A6EE43

Q27680873-3D603390-5F96-4E56-B6CE-21899DA0F9FF

Q27680873-73803EB8-4407-422D-B4C3-8052FC460780

Q27680873-7C504C9B-D5BF-4CAA-B2E5-5788D3D020D5

Q27680873-907D88C1-53C8-4DE0-9DD6-2F23EE3FFB5F

Q27680873-D19455BF-C5FF-4C33-9F1E-B3407CF60998

Q27680873-D4F597FF-AF4E-47F8-9744-1B60A6E6D1C0

Q27680873-EB5148CF-569E-43AB-A500-1FF41AD1B9C5

P577

Q27680873-390663AD-D057-46CD-9AAC-53971D2B7C56

P5875

Q27680873-89FA98ED-6AC5-4B3E-9247-21D260C29589

P698

Q27680873-73BE9E08-5B32-4DEA-9D7D-85A05F260265

P932

Q27680873-E034EDA3-F29D-4E48-8928-9BA52371328B

P3181

P356

PNAS.1319058110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A common solution to group 2 influenza virus neutralization

@en

P2093

Andrew B Ward

http://www.w3.org/2001/XMLSchema#string

Arjen Q Bakker

http://www.w3.org/2001/XMLSchema#string

Carla Ophorst

http://www.w3.org/2001/XMLSchema#string

Damian C Ekiert

http://www.w3.org/2001/XMLSchema#string

Els C M Brinkman-van der Linden

http://www.w3.org/2001/XMLSchema#string

Esther J M Stoop

http://www.w3.org/2001/XMLSchema#string

Hans J W M Korse

http://www.w3.org/2001/XMLSchema#string

Hergen Spits

http://www.w3.org/2001/XMLSchema#string

Mark J Kwakkenbos

http://www.w3.org/2001/XMLSchema#string

Mark Throsby

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Highly Conserved Protective Epitopes on Influenza B Viruses

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

Cross-neutralization of influenza A viruses mediated by a single antibody loop

P304

445-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

454297

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1319058110

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Wouter Koudstaal

Mandy Jongeneelen

Ian Andrew Wilson

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259320517

http://www.w3.org/2001/XMLSchema#string

P698

24335589

http://www.w3.org/2001/XMLSchema#string

P932

3890827

http://www.w3.org/2001/XMLSchema#string